Arakawa A - Search Results

1

Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder.

Tsukishiro S, Suzumori N, Nishikawa H, Arakawa A, Suzumori K. Tsukishiro S, et al. Among authors: arakawa a. Gynecol Oncol. 2006 Sep;102(3):542-5. doi: 10.1016/j.ygyno.2006.01.029. Epub 2006 Feb 28. Gynecol Oncol. 2006. PMID: 16510173

2

The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer.

Nishikawa H, Ozaki Y, Nakanishi T, Blomgren K, Tada T, Arakawa A, Suzumori K. Nishikawa H, et al. Among authors: arakawa a. Gynecol Oncol. 2004 Mar;92(3):881-6. doi: 10.1016/j.ygyno.2003.11.017. Gynecol Oncol. 2004. PMID: 14984956

3

Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis.

Tsukishiro S, Suzumori N, Nishikawa H, Arakawa A, Suzumori K. Tsukishiro S, et al. Among authors: arakawa a. Gynecol Oncol. 2005 Feb;96(2):516-9. doi: 10.1016/j.ygyno.2004.10.036. Gynecol Oncol. 2005. PMID: 15661245

4

Preoperative serum thrombopoietin levels are higher in patients with ovarian cancer than with benign cysts.

Tsukishiro S, Suzumori N, Nishikawa H, Arakawa A, Suzumori K. Tsukishiro S, et al. Among authors: arakawa a. Eur J Obstet Gynecol Reprod Biol. 2008 Sep;140(1):67-70. doi: 10.1016/j.ejogrb.2005.10.037. Epub 2005 Dec 15. Eur J Obstet Gynecol Reprod Biol. 2008. PMID: 16359773

5

Clinical significance of serum growth-regulated oncogene alpha (GROalpha) in patients with gynecological cancer.

Nishikawa R, Suzumori N, Nishiyama T, Nishikawa H, Arakawa A, Sugiura-Ogasawara M. Nishikawa R, et al. Among authors: arakawa a. Eur J Gynaecol Oncol. 2012;33(2):138-41. Eur J Gynaecol Oncol. 2012. PMID: 22611950

6

Mutational analysis of FOXL2 p.C134W and expression of bone morphogenetic protein 2 in Japanese patients with granulosa cell tumor of ovary.

Oseto K, Suzumori N, Nishikawa R, Nishikawa H, Arakawa A, Ozaki Y, Asai H, Kawai M, Mizuno K, Takahashi S, Shirai T, Yamada-Namikawa C, Nakanishi M, Kajiyama H, Kikkawa F, Sugiura-Ogasawara M. Oseto K, et al. Among authors: arakawa a. J Obstet Gynaecol Res. 2014 May;40(5):1197-204. doi: 10.1111/jog.12324. Epub 2014 Apr 2. J Obstet Gynaecol Res. 2014. PMID: 24689977

7

Usefulness of immunohistochemistry for the detection of the BRAF V600E mutation in ovarian serous borderline tumors.

Hayashi Y, Sasaki H, Takeshita S, Nishikawa R, Nishikawa H, Arakawa A, Yamashita Y, Takahashi S, Sugiura-Ogasawara M. Hayashi Y, et al. Among authors: arakawa a. Oncol Rep. 2014 Nov;32(5):1815-9. doi: 10.3892/or.2014.3442. Epub 2014 Aug 25. Oncol Rep. 2014. PMID: 25174456

8

Pharmacokinetic and pharmacodynamic analysis of combined chemotherapy with carboplatin and paclitaxel for patients with ovarian cancer.

Arakawa A, Nishikawa H, Suzumori K, Kato N. Arakawa A, et al. Int J Clin Oncol. 2001 Oct;6(5):248-52. doi: 10.1007/pl00012113. Int J Clin Oncol. 2001. PMID: 11723747

9

FISH analysis of BRCA1 copy number in paraffin-embedded ovarian cancer tissue samples.

Kato H, Arakawa A, Suzumori K, Kataoka N, Young SR. Kato H, et al. Among authors: arakawa a. Exp Mol Pathol. 2004 Apr;76(2):138-42. doi: 10.1016/j.yexmp.2003.11.005. Exp Mol Pathol. 2004. PMID: 15010292

10

[The value of a Tenckhoff catheter in ovarian cancer].

Kato N, Arakawa A, Yasui Y, Suzumori K, Suzumori K, Yagami Y. Kato N, et al. Among authors: arakawa a. Gan To Kagaku Ryoho. 1991 May;18(6):1025-30. Gan To Kagaku Ryoho. 1991. PMID: 2029187 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

485 results

Search Page